Skip to main content

Table 1 Sample characteristics at baseline (N = 955)

From: The course of depressive symptoms with decline in cognitive function - a longitudinal study of older adults receiving in-home care at baseline

   All
N = 955
No MCI or Dementia
N = 295
MCI
N = 266
Dementia
N = 394
Socio-demographics
 Age Mean (SD) 83.4 (5.6) 81.7 (5.6) 83.4 (5.4) 84.6 (5.5)
 Females N (%) 653 (68.4) 202 (68.5) 188 (70.7) 263 (66.8)
 Marrieda N (%) 287 (30.1) 81 (27.5) 80 (30.2) 126 (32.0)
Health condition
 GMHRa
  Good N (%) 149 (15.6) 67 (22.7) 42 (15.8) 40 (10.2)
  Fairly good N (%) 378 (39.6) 127 (43.1) 109 (41.0) 142 (36.1)
  Poor N (%) 326 (34.2) 80 (27.1) 93 (35.0) 153 (38.9)
  Very Poor N (%) 101 (10.6) 21 (7.1) 22 (8.3) 58 (14.8)
P-ADL scoreb Mean (SD) 9.1 (3.5) 7.6 (2.1) 8.4 (3.0) 10.8 (4.0)
I-ADL scoreb Mean (SD) 5.2 (2.4) 6.6 (1.6) 5.9 (2.0) 3.6 (2.2)
CDR-SoB Mean (SD) 3.2 (3.8) 0.8 (1.4) 1.6 (2.0) 6.1 (4.0)
Neuropsychiatric sub-syndrome score
 Agitationc Mean (SD) 1.7 (4.6) 0.7 (2.7) 1.1 (3.1) 2.8 (6.1)
 Psychosisc Mean (SD) 0.5 (2.0) 0.1 (0.5) 0.2 (1.5) 1.1 (2.8)
 Affectivec Mean (SD) 2.9 (5.3) 1.1 (2.6) 2.2 (3.9) 4.7 (6.8)
Use of psychotropic medication
 Antipsychotics N (%) 36 (3.8) 5 (1.7) 7 (2.6) 24 (6.1)
 Antidepressants N (%) 148 (15.5) 32 (10.9) 38 (14.3) 78 (19.8)
 Anxiolytics N (%) 84 (8.8) 15 (5.1) 27 (10.2) 42 (10.7)
 Sedatives N (%) 211 (22.1) 54 (18.3) 59 (22.2) 98 (24.9)
 Cognitive enhancers N (%) 54 (5.7) 0 4 (1.5) 50 (12.7)
No of drugs Mean (SD) 5.4 (2.9) 5.1 (3.1) 5.4 (2.8) 5.5 (2.9)
  1. MCI Mild Cognitive Impairment, GMHR General Medical Health Rating Scale, P-ADL Personal functioning assessed with Lawton and Brody’s Physical Self-Maintenance Scale, I-ADL Instrumental functioning assessed with Instrumental Activities of Daily Living Scale, CDR-SoB Clinical Dementia Rating Scale with sum of boxes
  2. aMissing information from one participant
  3. bMissing information from three participants
  4. cMissing information from two participants